Education
About Us
Working with TipRanks
Follow Us
LIDDS AB (SE:LIDDS)
:LIDDS
LIDDS Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.03 - kr0.23
Previous CloseN/A
Volume21.10K
Average Volume (3M)175.75K
Market Cap
kr2.73M
Enterprise ValueN/A
Total Cash (Recent Filing)kr10.95M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.96
Next Earnings
May 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding68,231,670
10 Day Avg. Volume164,524
30 Day Avg. Volume175,745
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
LIDDS FAQ
What was LIDDS AB’s price range in the past 12 months?
LIDDS AB lowest stock price was kr0.03 and its highest was kr0.23 in the past 12 months.
What is LIDDS AB’s market cap?
LIDDS AB’s market cap is kr2.73M.
When is LIDDS AB’s upcoming earnings report date?
LIDDS AB’s upcoming earnings report date is May 20, 2025 which is in 23 days.
How were LIDDS AB’s earnings last quarter?
LIDDS AB released its earnings results on Feb 20, 2025. The company reported -kr0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.007.
Is LIDDS AB overvalued?
According to Wall Street analysts LIDDS AB’s price is currently Overvalued.
Does LIDDS AB pay dividends?
LIDDS AB does not currently pay dividends.
What is LIDDS AB’s EPS estimate?
LIDDS AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LIDDS AB have?
LIDDS AB has 68,231,670 shares outstanding.
What happened to LIDDS AB’s price movement after its last earnings report?
LIDDS AB reported an EPS of -kr0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of LIDDS AB?
Currently, no hedge funds are holding shares in SE:LIDDS
---
Company Description
LIDDS AB
LIDDS AB (LIDDS) is a Swedish pharmaceutical company that specializes in the development of innovative drug delivery systems for cancer treatments and other therapeutic areas. The company leverages its proprietary NanoZolid® technology to create injectable, controlled-release formulations that enhance the efficacy and safety profiles of active pharmaceutical ingredients. By focusing on improving drug delivery, LIDDS aims to address unmet medical needs and enhance patient outcomes across various clinical indications.
---
Technical Analysis
QuiaPEG Pharmaceuticals Holding AB
―
Scandion Oncology A/S
―
Spago Nanomedical AB
―
---